index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique

Dernières publications

Chiffres clés

53 Publications avec texte intégral

Open Access

75 %

Mots clés

Genomic Dynamin 2 Duchenne muscular dystrophy Cells DMD Animal/physiopathology LncARN Dystrophie Musculaire de Duchenne DMD Inhibitors Muscle development L-Type Dilated Cardiomyopathy LncRNA DHPR α1S Becker Muscular Dystrophy Becker BMD muscular dystrophy Calcium Channels Dystrophy Diseases BMD Clinical trials Multi resolution modeling Gene Expression Regulation/drug effects Skeletal muscle Epigenetics MiARN CaVβs Cell Line Homeostasis Antisense oligonucleotides Mitochondrial fission Hear Dystrophin-EGFP Cell homeostasis Muscle damage Humans Inbred C57BL Dystrophin Molecular Sequence Data Long QT Drp1 Activin Receptors Duchenne muscular dystrophy DMD Multiresolution modeling Invivo Duchenne DMD dystrophy CD38 Base Sequence Calcium Becker muscular dystrophy Molecular docking Génomique Gene expression Liver LKB1 Mdx mouse Muscle Dystrophie musculaire de Becker Adult muscle stem cells Human Umbilical Vein Endothelial Cells Mice Long noncoding RNA Dystrophin central domain Muscle cell fusion Cultured Morphogenesis Multi exon skipping Cachexia Autophagy Inbred mdx CaV subunits Muscle Biology Energy Metabolism/drug effects Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Connexins Modificateurs de gènes Dystrophie Musculaire de Becker BMD Muscle hypertrophy Animals Exon skipping CTNNB1 Immunoglobulin Fc Fragments/pharmacology Centronuclear myopathy Hepatocellular carcinoma DMO MES Cardiomyopathy Heart Failure Allele‐specific silencing therapy Dystrophine Gene modifiers Muscle Strength Metabolism Becker muscular dystrophy BMD Knockout Delivery Ex-vivo Cardiomyopathie Cell Biology Male